Published on Aug 18, 2026
What if the pill bottle on your pharmacy shelf could help save the planet - while still protecting patients and meeting strict regulations?
As we move through 2026, pharmaceutical packaging is being reshaped not only by safety and compliance requirements, but also by sustainability and environmental responsibility. These pressures are converging - creating both challenges and opportunities for pharma companies, packaging designers, and suppliers alike.
Regulatory frameworks are tightening
The EU Packaging and Packaging Waste Regulation (PPWR) has been formally adopted, with requirements being phased in over the coming years.
Under the PPWR, packaging will increasingly need to meet recyclability criteria, reduce unnecessary material use and empty space, and incorporate higher levels of recycled content where technically feasible. However, in the pharmaceutical sector, implementation will necessarily account for product safety, sterility, stability, and regulatory compliance requirements, with certain exemptions and adaptations expected.
For pharmaceutical companies, this means packaging strategies must be reconsidered early - spanning materials, formats, and supply-chain design - while maintaining strict adherence to drug safety standards.
Sustainability is now a baseline expectation
‘Green pharma packaging’ is no longer a niche ambition - it is becoming a standard expectation across regulators, healthcare systems, investors, and patients.
There is growing demand for:
At the same time, ESG considerations are increasingly embedded into procurement decisions, making sustainable packaging capability a competitive differentiator.
Packaging suppliers who can demonstrate life-cycle assessment (LCA) capability, material innovation, and credible sustainability certifications are becoming preferred partners for pharmaceutical brands.
Safety and patient-centric design remain non-negotiable
Sustainability must be achieved without compromising patient safety, usability, or regulatory compliance.
At the same time, pharmaceutical packaging continues to evolve in two important directions:
The challenge, and opportunity, is to balance environmental goals with usability, compliance, and product integrity.
What this means for pharmaceutical companies and suppliers
Companies that invest early in sustainable packaging design - supported by material research, regulatory foresight, and life-cycle analysis - will be better positioned to avoid costly redesigns later.
Cross-functional collaboration is becoming essential, bringing together formulation scientists, packaging engineers, regulatory affairs, and quality teams to ensure packaging decisions support both compliance and market success.
Packaging suppliers offering adaptable, compliant, and sustainability-driven solutions will hold a clear competitive advantage.
Why this matters - and why now
Sustainability in pharmaceutical packaging is no longer a future consideration; it is becoming a baseline requirement shaped by regulation, ESG expectations, and patient safety priorities.
For organisations across drug development, manufacturing, and packaging, understanding these shifts is now a strategic necessity.
Want to dig deeper?
If you’re interested in mastering how to navigate these evolving demands - from regulation and compliance to design, supply-chain strategy, and market success - consider joining our course:
Pharmaceutical Packaging Essentials: From Regulatory Compliance to Market Success
Designed to equip you with current best practices, regulatory insight, and forward-looking approaches in pharmaceutical packaging.
Enrol here:
Published on Aug 18, 2026 by Simóne Blair